Technological Advances in Biobetter and Biosimilar Platforms

1.1 Research Focus – Biosimilars and Biobetters

1.2 Research Scope – Foreseeing Challenges and Solutions

1.3 Analysis Framework – Frost & Sullivan’s Core Value

1.4 Research Methodology

2.1 Biosimilars and Biobetters – Two Different Approaches

2.2 Biosimilars and Biobetters – Facts and Opportunities

2.3 Biosimilars and Biobetters – Drawbacks and Challenges

3.1 The Biopharmaceutical Industry – Operational Trends

3.2 The Biopharmaceutical Industry – Business Evolution

3.3 The Biopharmaceutical Industry – Business Ecosystem

3.4 The Biopharmaceutical Industry – Technology Focus

3.5 The Biopharmaceutical Industry – Process Optimization

3.6 The Biopharmaceutical Industry – Upstream Process

3.7 The Biopharmaceutical Industry – Downstream Process

3.8 Process Technology Disruptiveness Opportunities

3.9 Bioprocessing Units and Facility Types – Fed Batch

3.10 Large-scale Stainless Steel Fed Batch

3.11 Bioprocessing Units and Facility Types – Single Use Bioreactors

3.12 Single Use Bioreactors

3.13 Bioprocessing Units and Facility Types – Small-scale Bioreactors

3.14 Small Scale Bioreactors

4.1 Biobetters – Biochemical Improvements

4.2 Biobetters – Biomanufacturing Improvements

4.3 Biobetters – Enhanced Characteristics

4.4 Biosimilars Pipeline Impacting the Biopharmaceutical Market

4.5 Pipeline Products by Development Status

4.6 Pipeline Products by Country

4.7 Marketed Products by Reference Type

5.1 Biosimilars and Biobetters Market Potential

5.2 Biosimilars and Biobetters Market Forecast by Product Type

5.3 Biosimilars and Biobetters Market Growth by Product Type

5.4 Biosimilars and Biobetters Market Forecast by Region

5.5 Biosimilars and Biobetters Market Growth by Region

5.6 Market Adoption Trends for Biosimilars and Biobetters

6.1 Actionable Impact on Customers

6.2 Repercussions in Business and Processes

6.3 Patenting Trends and Major Focus

6.4 Technology Transfer Assessment

7.1 Typical Value Chain Interactive Model

7.2 Biomanufacturing Technology Roadmap

7.3 Industry Intersection Model

7.4 Crossmapping Continuous Biosimilars Innovations

8.1 Overall Environmental Impact Factors

8.2 Best-fit Industry Partnerships – SWOT Analysis

8.3 Novel Business Models to Monetize Biosimilars and Biobetters

8.4 Partners Business and Technology Capabilities

8.5 Strategic Imperatives for Future Growth

9.1 Key Industry Influencers

9.2 Key Industry Experts

9.3 Key Industry Authorities

9.4 Key Industry Advisors

9.5 Key Industry Mentors

Legal Disclaimer